California Institute of Renal Research, Inc. Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: San Diego CA United States (2000)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2008
NCT00817206
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Claifornia Institute of Renal Research/Sharp Memorial

Active Ingredients

Drugs in Phase 4 Trials (2)

bacitracin (polysporin) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 3 Trials (1)

tacrolimus (prograf) (1 trial)

Drugs in Phase 2 Trials (1)

vascugel (2 trials)

Drugs in Phase 1 Trials (1)

gcs-100 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteriovenous Fistula (Phase 4)

Fistula (Phase 4)

Kidney Diseases (Phase 1)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5